Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Nov 1;182(5):1259–1264. doi: 10.1084/jem.182.5.1259

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

PMCID: PMC2192198  PMID: 7595196

Abstract

Recent studies have shown that mucocutaneous leishmaniasis (MCL), a severe and debilitating form of American cutaneous leishmaniasis (ACL) caused by Leishmania braziliensis infection, is accompanied by high circulating levels of tumor necrosis factor (TNF)-alpha. Analysis of TNF polymorphisms in Venezuelan ACL patients and endemic unaffected controls demonstrates a high relative risk (RR) of 7.5 (P < 0.001) of MCL disease in homozygotes for allele 2 of a polymorphism in intron 2 of the TNF-beta gene, especially in females (RR = 9.5; P < 0.001) compared with males (RR = 4; P < 0.05). A significantly higher frequency (P < 0.05) of allele 2 at the -308-basepair TNF-alpha gene polymorphism was also observed in MCL patients (0.18) compared with endemic control subjects (0.069), again associated with a high relative risk of disease (RR = 3.5; P < 0.05) even in the heterozygous condition. Because both the TNF-alpha and TNF-beta polymorphisms have previously been linked with functional differences in TNF-alpha levels, these data suggest that susceptibility to the mucocutaneous form of disease may be directly associated with regulatory polymorphisms affecting TNF-alpha production.

Full Text

The Full Text of this article is available as a PDF (558.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham L. J., French M. A., Dawkins R. L. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol. 1993 Apr;92(1):14–18. doi: 10.1111/j.1365-2249.1993.tb05940.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bendtzen K., Morling N., Fomsgaard A., Svenson M., Jakobsen B., Odum N., Svejgaard A. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol. 1988 Nov;28(5):599–606. doi: 10.1111/j.1365-3083.1988.tb01492.x. [DOI] [PubMed] [Google Scholar]
  3. Castes M., Agnelli A., Verde O., Rondón A. J. Characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Immunol Immunopathol. 1983 May;27(2):176–186. doi: 10.1016/0090-1229(83)90068-5. [DOI] [PubMed] [Google Scholar]
  4. Castes M., Cabrera M., Trujillo D., Convit J. T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis. J Clin Microbiol. 1988 Jun;26(6):1207–1213. doi: 10.1128/jcm.26.6.1207-1213.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Castes M., Trujillo D., Rojas M. E., Fernandez C. T., Araya L., Cabrera M., Blackwell J., Convit J. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol Res. 1993;26(1-2):233–238. [PubMed] [Google Scholar]
  6. Castés M., Agnelli A., Rondón A. J. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis. Clin Exp Immunol. 1984 Aug;57(2):279–286. [PMC free article] [PubMed] [Google Scholar]
  7. Castés M., Blackwell J., Trujillo D., Formica S., Cabrera M., Zorrilla G., Rodas A., Castellanos P. L., Convit J. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production. Vaccine. 1994 Aug;12(11):1041–1051. doi: 10.1016/0264-410x(94)90342-5. [DOI] [PubMed] [Google Scholar]
  8. Convit J., Ulrich M., Fernández C. T., Tapia F. J., Cáceres-Dittmar G., Castés M., Rondón A. J. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):444–448. doi: 10.1016/0035-9203(93)90030-t. [DOI] [PubMed] [Google Scholar]
  9. Cox N. J., Mela A. P., Zmijewski C. M., Spielman R. S. HLA-DR typing "at the DNA level": RFLPs and subtypes detected with a DR beta cDNA probe. Am J Hum Genet. 1988 Dec;43(6):954–963. [PMC free article] [PubMed] [Google Scholar]
  10. Cáceres-Dittmar G., Tapia F. J., Sánchez M. A., Yamamura M., Uyemura K., Modlin R. L., Bloom B. R., Convit J. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol. 1993 Mar;91(3):500–505. doi: 10.1111/j.1365-2249.1993.tb05931.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fugger L., Morling N., Ryder L. P., Platz P., Georgsen J., Jakobsen B. K., Svejgaard A., Dalhoff K., Ranek L. NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNF alpha) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol. 1989 Aug;30(2):185–189. doi: 10.1111/j.1365-3083.1989.tb01200.x. [DOI] [PubMed] [Google Scholar]
  12. Jacob C. O., Fronek Z., Lewis G. D., Koo M., Hansen J. A., McDevitt H. O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1233–1237. doi: 10.1073/pnas.87.3.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lara M. L., Layrisse Z., Scorza J. V., Garcia E., Stoikow Z., Granados J., Bias W. Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. Hum Immunol. 1991 Feb;30(2):129–135. doi: 10.1016/0198-8859(91)90081-j. [DOI] [PubMed] [Google Scholar]
  14. McGuire W., Hill A. V., Allsopp C. E., Greenwood B. M., Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994 Oct 6;371(6497):508–510. doi: 10.1038/371508a0. [DOI] [PubMed] [Google Scholar]
  15. Messer G., Spengler U., Jung M. C., Honold G., Blömer K., Pape G. R., Riethmüller G., Weiss E. H. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991 Jan 1;173(1):209–219. doi: 10.1084/jem.173.1.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceiço-Silva F., Modlin R. L. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest. 1993 Apr;91(4):1390–1395. doi: 10.1172/JCI116341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pociot F., Briant L., Jongeneel C. V., Mölvig J., Worsaae H., Abbal M., Thomsen M., Nerup J., Cambon-Thomsen A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 1993 Jan;23(1):224–231. doi: 10.1002/eji.1830230135. [DOI] [PubMed] [Google Scholar]
  18. Pociot F., Mølvig J., Wogensen L., Worsaae H., Dalbøge H., Baek L., Nerup J. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol. 1991 Jan;33(1):37–49. doi: 10.1111/j.1365-3083.1991.tb02490.x. [DOI] [PubMed] [Google Scholar]
  19. Sharples C. E., Shaw M. A., Castes M., Convit J., Blackwell J. M. Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes: antibody responses to mycobacterial and leishmanial antigens. Vaccine. 1994 Nov;12(15):1402–1412. doi: 10.1016/0264-410x(94)90149-x. [DOI] [PubMed] [Google Scholar]
  20. Trowsdale J. Genomic structure and function in the MHC. Trends Genet. 1993 Apr;9(4):117–122. doi: 10.1016/0168-9525(93)90205-v. [DOI] [PubMed] [Google Scholar]
  21. Wilson A. G., di Giovine F. S., Blakemore A. I., Duff G. W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992 Aug;1(5):353–353. doi: 10.1093/hmg/1.5.353. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES